Pressmeddelanden, rapporter och bolagsmeddelande för Inhalation Sciences

Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Inhalation Sciences

Press release from Companies: Inhalation Sciences provides latest status update on ongoing FDA BAA dissolution research project
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Inhalation Sciences

Press release from Companies: Inhalation Sciences provides latest status update on ongoing FDA BAA dissolution research project
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Inhalation Sciences

Press release from Companies: Publication of positive performance of ISAB’s in vitro module demonstrated in collaboration with Karolinska Institutet
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Inhalation Sciences

Press release from Companies: Kommuniké från extra bolagsstämma i Inhalation Sciences Sweden AB (publ)
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Inhalation Sciences

Press release from Companies: Inhalation Sciences AB (publ) publicerar delårsrapport för andra kvartalet 2024
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Inhalation Sciences

Press release from Companies: Inhalation Sciences AB (publ) releases Q2 Report 2024
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Inhalation Sciences

Press release from Companies: KALLELSE TILL EXTRA BOLAGSTÄMMA i INHALATION SCIENCES SWEDEN AB (PUBL)
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Inhalation Sciences

Press release from Companies: Surge of new orders totalling 50,000 Euro signals new sales season for Inhalation Research Services
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Inhalation Sciences

Press release from Companies: Forthcoming changes in Inhalation Sciences’ Board of Directors
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Inhalation Sciences

Press release from Companies: Inhalation Sciences receives new IRS order for DissolvIt® study worth 57,000 Euro from leading inhalation big pharma